The University of Chicago Header Logo

Connection

Ralph Weichselbaum to Tumor Microenvironment

Back to Details
This is a "connection" page, showing publications Ralph Weichselbaum has written about Tumor Microenvironment.
Ralph Weichselbaum
Connection Strength
3.194
Tumor Microenvironment
  1. Radiotherapy, immunity, and immune checkpoint inhibitors. Lancet Oncol. 2024 08; 25(8):e352-e362.
    View in: PubMed
    Score: 0.607
  2. Radiotherapy and immunology. J Exp Med. 2024 07 01; 221(7).
    View in: PubMed
    Score: 0.599
  3. Radiation as an immune modulator. Semin Radiat Oncol. 2013 Oct; 23(4):273-80.
    View in: PubMed
    Score: 0.286
  4. Facts and Hopes in Radioimmunotherapy of Oligometastatic Disease. Clin Cancer Res. 2025 Jul 01; 31(13):2556-2564.
    View in: PubMed
    Score: 0.162
  5. YTHDFs as radiotherapy checkpoints in tumor immunity. J Exp Med. 2025 Aug 04; 222(8).
    View in: PubMed
    Score: 0.161
  6. Epitranscriptional regulation of TGF-ß pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance. J Clin Invest. 2023 12 15; 133(24).
    View in: PubMed
    Score: 0.145
  7. RNA m6A methylation and MDSCs: Roles and therapeutic implications for radiotherapy. Med. 2023 12 08; 4(12):863-874.
    View in: PubMed
    Score: 0.145
  8. Metastasis. Cancer Cell. 2022 08 08; 40(8):787-791.
    View in: PubMed
    Score: 0.132
  9. Systemic delivery of the tumor necrosis factor gene to tumors by a novel dual DNA-nanocomplex in a nanoparticle system. Nanomedicine. 2017 07; 13(5):1833-1839.
    View in: PubMed
    Score: 0.091
  10. Radiotherapy and immunotherapy: a beneficial liaison? Nat Rev Clin Oncol. 2017 Jun; 14(6):365-379.
    View in: PubMed
    Score: 0.090
  11. Targeting the tumor microenvironment with interferon-ß bridges innate and adaptive immune responses. Cancer Cell. 2014 Jan 13; 25(1):37-48.
    View in: PubMed
    Score: 0.073
  12. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. J Clin Invest. 2014 Feb; 124(2):687-95.
    View in: PubMed
    Score: 0.073
  13. Engineered probiotic Bifidobacterium for tumor-targeted pancreatic cancer therapy. Sci Adv. 2026 Jul 24; 12(30):eadz1388.
    View in: PubMed
    Score: 0.043
  14. NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity. Nature. 2025 09; 645(8082):1051-1059.
    View in: PubMed
    Score: 0.041
  15. Designing live bacterial therapeutics for cancer. Adv Drug Deliv Rev. 2025 06; 221:115579.
    View in: PubMed
    Score: 0.040
  16. Bifunctional Metal-Organic Framework Synergistically Enhances Radiotherapy and Activates STING for Potent Cancer Radio-Immunotherapy. Angew Chem Int Ed Engl. 2025 Jan 27; 64(5):e202417027.
    View in: PubMed
    Score: 0.039
  17. Multifunctional Nanomaterials Mediate Cholesterol Depletion for Cancer Treatment. Angew Chem Int Ed Engl. 2024 11 11; 63(46):e202412844.
    View in: PubMed
    Score: 0.038
  18. Digitonin-Loaded Nanoscale Metal-Organic Framework for Mitochondria-Targeted Radiotherapy-Radiodynamic Therapy and Disulfidptosis. Adv Mater. 2025 Dec; 37(52):e2405494.
    View in: PubMed
    Score: 0.038
  19. Mechanoregulatory Cholesterol Oxidase-Functionalized Nanoscale Metal-Organic Framework Stimulates Pyroptosis and Reinvigorates T Cells. Small. 2023 12; 19(52):e2305440.
    View in: PubMed
    Score: 0.036
  20. Western Diet-induced Transcriptional Changes in Anastomotic Tissue Is Associated With Early Local Recurrence in a Mouse Model of Colorectal Surgery. Ann Surg. 2023 12 01; 278(6):954-960.
    View in: PubMed
    Score: 0.035
  21. YTHDF2/m6 A/NF-?B axis controls anti-tumor immunity by regulating intratumoral Tregs. EMBO J. 2023 08 01; 42(15):e113126.
    View in: PubMed
    Score: 0.035
  22. Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy. Adv Mater. 2023 May; 35(21):e2206370.
    View in: PubMed
    Score: 0.035
  23. TLR3 agonist nanoscale coordination polymer synergizes with immune checkpoint blockade for immunotherapy of cancer. Biomaterials. 2022 11; 290:121831.
    View in: PubMed
    Score: 0.033
  24. Tumor-Activatable Nanoparticles Target Low-Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy. Adv Sci (Weinh). 2022 08; 9(24):e2201614.
    View in: PubMed
    Score: 0.033
  25. Synergistic checkpoint-blockade and radiotherapy-radiodynamic therapy via an immunomodulatory nanoscale metal-organic framework. Nat Biomed Eng. 2022 02; 6(2):144-156.
    View in: PubMed
    Score: 0.032
  26. All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages. Sci Immunol. 2021 06 15; 6(60).
    View in: PubMed
    Score: 0.031
  27. The relationship between expression of PD-L1 and HIF-1a in glioma cells under hypoxia. J Hematol Oncol. 2021 06 12; 14(1):92.
    View in: PubMed
    Score: 0.031
  28. Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling. J Exp Med. 2020 05 04; 217(5).
    View in: PubMed
    Score: 0.028
  29. Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors. Nat Commun. 2019 04 23; 10(1):1899.
    View in: PubMed
    Score: 0.026
  30. Image-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment. Mol Pharm. 2016 10 03; 13(10):3457-3467.
    View in: PubMed
    Score: 0.022
  31. The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res. 2011 Apr 01; 71(7):2488-96.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.